Table I.
Demographic data of the patients operated on
| Group | N | Sex | Age [years] | Value of p | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| F | M | Average | SD | Min | Max | |||||
| G (–) | ITP | 30 | 20 | 14 | 6 | 39.2 | 14.2 | 20 | 60 | NS |
| NHL | 10 | 4 | 6 | 55.3 | 15.2 | 26 | 78 | |||
| G (+) | ITP + G | 30 | 20 | 13 | 7 | 41.6 | 19.8 | 18 | 75 | |
| NHL + G | 10 | 4 | 6 | 56.4 | 7.1 | 49 | 71 | |||
G (–) – no Garamycin was used, G (+) – Garamycin was used, ITP – patients with idiopathic thrombocytopenic purpura who did not receive Garamycin, NHL – patients with non-Hodgkin lymphoma who did not receive Garamycin, ITP + G – patients with idiopathic thrombocytopenic purpura who received Garamycin, NHL + G – patients with non-Hodgkin lymphoma who received Garamycin